Pros and Cons of Marijuana in Treatment of Parkinson’s Disease
Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disorder of adult onset in the United States. It is…
medical marijuana
A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain
Abstract Background: A recent meta-analysis affirmed the benefit of medicinal cannabis for chronic neuropathic pain, a disabling and difficult-to-treat condition.…
Medical Marijuana Knowledge and Attitudes: A Survey of the California Pharmacists Association
Abstract Views on the medical efficacy and acceptability of marijuana have changed over the years. California was the first state…
A Review of Cannabis in Chronic Kidney Disease Symptom Management
Abstract Purpose of Review: Physical and psychological symptom burden in patients with advanced chronic kidney disease (CKD) is significantly debilitating;…
A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers
Abstract Background: Healthcare providers play a critical role in facilitating patient access to medical cannabis. However, previous surveys suggest only…
Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis
Abstract Introduction: Medical cannabis (MC) is commonly claimed to be an effective treatment for chronic or refractory pain. With interest…
A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes
Abstract Introduction: In Canada, the Access to Cannabis for Medical Purposes Regulations (ACMPR) has given nurse practitioners (NPs) the power…
New York Physicians’ Perspectives and Knowledge of the State Medical Marijuana Program
Abstract Introduction: In 2014, New York (NY) became the 23rd state to legalize medical marijuana (MMJ). The purpose of this…
Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey
Abstract Background: Regulatory barriers limit clinical trials of medical cannabis in the United States. Longitudinal cohort studies may be one…
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment
Abstract The vast majority of states have enacted full or partial medical marijuana (MMJ) programs, causing the number of patients…